Healthcare
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
Lexicon Genetics. United States. Announced Date 23/10/2006. Closed Date 26/10/2006. Deal value: $40m. Registered direct offering of common stock. Industry: Lexicon Genetics is a biopharmaceutical company focused on developing treatments for human diseases.